PTCT - PTC THERAPEUTICS, INC.


64.39
-1.980   -3.075%

Share volume: 1,259,674
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.15%

PREVIOUS CLOSE
CHG
CHG%

$66.37
-1.98
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 04-25-2024 08-08-2024 11-07-2024 02-27-2025 05-06-2025 08-07-2025 11-04-2025 02-19-2026
Total revenue 210.118 M 186.704 M 196.786 M 213.172 M 1.176 B 178.875 M 211.007 M 164.677 M
Cost of revenue 14.740 M 0.000 0.000 57.398 M 12.862 M 11.420 M 0.000 -24.282 M
Gross profit 195.378 M 186.704 M 196.786 M 155.774 M 1.163 B 167.455 M 211.007 M 188.959 M
    -4.44% 5.40% -20.84% 646.74% -85.60% 26.01% -10.45%  
Operating expenses 189.401 M 201.669 M 234.868 M 209.453 M 189.934 M 198.252 M 184.204 M 230.002 M
Selling general and admin 73.272 M 69.500 M 73.456 M 84.683 M 80.961 M 85.262 M 84.046 M 96.874 M
Research and development 116.129 M 132.169 M 161.412 M 124.770 M 108.973 M 112.990 M 100.158 M 133.128 M
Total expenses 255.671 M 226.922 M 251.296 M 318.163 M 193.009 M 202.412 M 207.991 M 260.308 M
    -11.24% 10.74% 26.61% -39.34% 4.87% 2.76% 25.15%  
Operating income -45.553 M -40.218 M -54.510 M -162.389 M 970.225 M -34.957 M 3.016 M -71.349 M
Ebit -45.553 M -42.243 M -56.382 M -153.539 M 963.920 M -40.694 M 9.518 M -83.895 M
Pretax income -84.696 M -85.733 M -97.991 M -94.699 M 929.828 M -71.052 M -23.074 M -139.083 M
    1.22% 14.30% -3.36% -1,081.88% -107.64% -67.53% 502.77%  
Income tax 6.880 M 13.446 M 8.663 M -28.813 M 63.266 M -6.203 M -38.970 M -4.118 M
Net income basic -91.576 M 0.000 0.000 0.000 0.000 0.000 0.000 0.000
    100.00%              
Net income -91.576 M -99.179 M -106.654 M -65.886 M 866.562 M -64.849 M 15.896 M -134.965 M
    -8.30% -7.54% 38.22% 1,415.24% -107.48% 124.51% -949.05%